1 study found for:    S0819
Show Display Options
Rank Status Study
1 Active, not recruiting Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Recurrent Large Cell Lung Carcinoma;   Recurrent Lung Adenocarcinoma;   Recurrent Squamous Cell Lung Carcinoma;   Stage IV Large Cell Lung Carcinoma;   Stage IV Lung Adenocarcinoma;   Stage IV Squamous Cell Lung Carcinoma
Interventions: Biological: Bevacizumab;   Drug: Carboplatin;   Biological: Cetuximab;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel

Indicates status has not been verified in more than two years